YassifJM, KorolS, KaneA. Guarding against catastrophic biological risks: preventing state biological weapon development and use by shaping intentions. Health Secur. 2023; 21(4):258-265.
2.
TomezskoPJ, PhillipsonCW, WalshME. Lessons learned from limited overlap of 15 in vitro COVID-19 drug repurposing screens. Health Secur. 2023; 21(4):249-257.
3.
MontazeriNX, SandbrinkJB. Innovate and stockpile: respiratory protection for essential workers in a catastrophic pandemic. Health Secur. 2023; 21(4):266-271.
4.
US Government Accountability Office. Operation Warp Speed: accelerating COVID-19 vaccine development status and efforts to address manufacturing challenges. Published February 22, 2021. Accessed June29, 2023. https://www.gao.gov/products/gao-21-319
5.
O'LearyCN, Barnes-WeiseJ, HoytK, BourdeauxM. Maintaining warp speed: policy requirements for a just-in-time, capability-based, scalable medical countermeasure research and development enterprise. Health Secur. 2023; 21(4):272-279.
